# Sands Capital Alternatives, LLC 13F Q2 2026: $614 million

Sands Capital Alternatives, LLC reported $614 million in 13F securities across 24 positions for the quarter ended June 30, 2026, in a holdings report filed August 13, 2026. Its largest holding was Alamar Biosciences Inc at $115 million, 18.7% of the reported value. Since Q1 2026 it opened 3 new positions and exited 0.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $613,546,175
- Positions: 24
- Filed: August 13, 2026
- Report type: 13F holdings report
- CIK: 1846444
- Form 13F file number: 028-21032
- CRD number: 155517
- Business address: 1000 Wilson Boulevard, Suite 3000, Arlington, VA 22209
- SEC filing: [0001846444-26-000009](https://www.sec.gov/Archives/edgar/data/1846444/000184644426000009/0001846444-26-000009-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/sands-capital-alternatives-llc-155517)

## Top 24 holdings by value

The largest of 24 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Alamar Biosciences Inc](https://specstream.ai/data/institutional-holders/alamar-biosciences-inc-010911105) | COMMON STOCK | 4,230,926 | $114.6 million | New |
| [Nu Hldgs LTD](https://specstream.ai/data/institutional-holders/nu-hldgs-ltd-g6683n103) | ORD SHS CL A | 7,094,952 | $94.8 million | +557,183 |
| [Klaviyo Inc](https://specstream.ai/data/institutional-holders/klaviyo-inc-49845k101) | COM SER A | 3,928,146 | $59.3 million | +278,468 |
| [Beta Bionics Inc](https://specstream.ai/data/institutional-holders/beta-bionics-inc-08659b102) | COM | 3,708,043 | $58.1 million | No change |
| [Spyglass Pharma Inc](https://specstream.ai/data/institutional-holders/spyglass-pharma-inc-85220g109) | COM SHS | 2,500,012 | $55.7 million | No change |
| [Inhibikase Therapeutics Inc](https://specstream.ai/data/institutional-holders/inhibikase-therapeutics-inc-45719w205) | COM NEW | 13,018,965 | $26.4 million | No change |
| [Doordash Inc](https://specstream.ai/data/institutional-holders/doordash-inc-25809k105) | CL A | 127,562 | $23.5 million | +16,331 |
| [Coupang Inc](https://specstream.ai/data/institutional-holders/coupang-inc-22266t109) | CL A | 1,329,314 | $23.1 million | +317,223 |
| [Datadog Inc](https://specstream.ai/data/institutional-holders/datadog-inc-23804l103) | CL A COM | 80,851 | $21.1 million | -4,942 |
| [Bioage Labs Inc](https://specstream.ai/data/institutional-holders/bioage-labs-inc-09077v100) | COM | 786,353 | $19.3 million | No change |
| [10x Genomics Inc](https://specstream.ai/data/institutional-holders/10x-genomics-inc-88025u109) | CL A COM | 481,770 | $18.5 million | No change |
| [Samsara Inc](https://specstream.ai/data/institutional-holders/samsara-inc-79589l106) | COM CL A | 515,658 | $16.7 million | -44,629 |
| [Odyssey Therapeutics Inc](https://specstream.ai/data/institutional-holders/odyssey-therapeutics-inc-67613t104) | COMMON STOCK | 875,000 | $16.4 million | New |
| [Toast Inc](https://specstream.ai/data/institutional-holders/toast-inc-888787108) | CL A | 364,879 | $10.2 million | +63,232 |
| [Acumen Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/acumen-pharmaceuticals-inc-00509g209) | COM | 3,720,105 | $9.9 million | No change |
| [Servicetitan Inc](https://specstream.ai/data/institutional-holders/servicetitan-inc-81764x103) | SHS CL A | 108,545 | $7.7 million | +18,689 |
| [Cerebras Systems Inc](https://specstream.ai/data/institutional-holders/cerebras-systems-inc-15675d103) | COM CL A | 32,825 | $7.3 million | New |
| [Snowflake Inc](https://specstream.ai/data/institutional-holders/snowflake-inc-833445109) | COM SHS | 24,498 | $6.2 million | +4,245 |
| [Monday Com LTD](https://specstream.ai/data/institutional-holders/monday-com-ltd-m7s64h106) | SHS | 81,982 | $5.9 million | +14,114 |
| [Tarsus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/tarsus-pharmaceuticals-inc-87650l103) | COM | 85,000 | $5.3 million | No change |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 724,873 | $4.9 million | No change |
| [Candel Therapeutics Inc](https://specstream.ai/data/institutional-holders/candel-therapeutics-inc-137404109) | COM | 405,837 | $4.2 million | No change |
| [Acrivon Therapeutics Inc](https://specstream.ai/data/institutional-holders/acrivon-therapeutics-inc-004890109) | COMMON STOCK | 2,289,271 | $4.1 million | +166,666 |
| [Figma Inc](https://specstream.ai/data/institutional-holders/figma-inc-316841105) | CLASS A COM STK | 22,165 | $400,965 | +3,879 |

## New positions in Q2 2026

3 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Alamar Biosciences Inc](https://specstream.ai/data/institutional-holders/alamar-biosciences-inc-010911105) | COMMON STOCK | 4,230,926 | $114.6 million |
| [Odyssey Therapeutics Inc](https://specstream.ai/data/institutional-holders/odyssey-therapeutics-inc-67613t104) | COMMON STOCK | 875,000 | $16.4 million |
| [Cerebras Systems Inc](https://specstream.ai/data/institutional-holders/cerebras-systems-inc-15675d103) | COM CL A | 32,825 | $7.3 million |

## Also on SpecStream

- [Sands Capital Alternatives, LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1846444/000184644426000009/0001846444-26-000009-index.htm)
- [Sands Capital Alternatives, LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/sands-capital-alternatives-llc-155517)
- [Largest 13F filers in Virginia](https://specstream.ai/data/institutional-holdings/state/virginia)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Arlington, Virginia

- [Bakeries in Arlington, Virginia](https://specstream.ai/data/businesses/bakeries/arlington-virginia-united-states)
- [Marketing agencies in Arlington, Virginia](https://specstream.ai/data/businesses/marketing-agencies/arlington-virginia-united-states)
- [Engineering firms in Arlington, Virginia](https://specstream.ai/data/businesses/engineering-firms/arlington-virginia-united-states)
- [Business consulting firms in Arlington, Virginia](https://specstream.ai/data/businesses/business-consulting-firms/arlington-virginia-united-states)
- [Physical therapy clinics in Arlington, Virginia](https://specstream.ai/data/businesses/physical-therapy-clinics/arlington-virginia-united-states)
- [General dentistry practices in Arlington, Virginia](https://specstream.ai/data/businesses/general-dentistry-practices/arlington-virginia-united-states)
